Mandate

VINGE ADVISES LITORINA IN CONNECTION WITH SALE OF TEXTILIA

October 16, 2014

Vinge has advised Litorina in connection with the sale of its shareholding in Textilia to the investment fund Accent Equity. Textilia is Sweden’s leading supplier of textile services to the healthcare sector. Members of management and the board of directors will retain their shares and thus continue as major shareholders following completion of the transaction. Completion of the transaction is conditional upon, among other things, approval by the Swedish Competition Authority. Closing is expected to occur at the end of 2014.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Joacim Rydergård, Charlotta Järnstedt and Johan Cederblad (environmental) and paralegal Pernilla Warg.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026